Kaye J Williams Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

11/2018

Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kaye J Williams Research Topics

Disease

50	Neoplasms (Cancer) 01/2023 - 01/2002
31	Hypoxia (Hypoxemia) 07/2021 - 02/2002
8	Neoplasm Metastasis (Metastasis) 08/2015 - 06/2005
7	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2003
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2019 - 03/2010
4	Thyroid Neoplasms (Thyroid Cancer) 09/2016 - 01/2011
4	Carcinoma (Carcinomatosis) 10/2015 - 10/2003
3	Cardiotoxicity 01/2024 - 12/2011
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2020
3	Necrosis 01/2020 - 01/2017
3	Hepatocellular Carcinoma (Hepatoma) 10/2015 - 02/2002
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2019
2	Neuroinflammatory Diseases 01/2022 - 05/2018
2	Prostatic Neoplasms (Prostate Cancer) 07/2021 - 01/2017
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021 - 09/2016
2	Lung Neoplasms (Lung Cancer) 11/2020 - 11/2009
2	Glioma (Gliomas) 01/2020 - 05/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 12/2004
2	Head and Neck Neoplasms (Head and Neck Cancer) 11/2018 - 01/2004
2	Fibrosarcoma 04/2016 - 04/2007
2	Colorectal Neoplasms (Colorectal Cancer) 10/2013 - 11/2009
1	AIDS-Related Complex (ARC) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 11/2018

Drug/Important Bio-Agent (IBA)

12	Oxygen (Dioxygen)IBA 01/2019 - 05/2002
8	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2013
7	Proteins (Proteins, Gene)FDA Link 01/2016 - 05/2002
6	Carbonic Anhydrase IXIBA 12/2019 - 06/2012
6	EnzymesIBA 04/2013 - 02/2002
5	Phosphotransferases (Kinase)IBA 01/2021 - 11/2009
5	Oxidoreductases (Dehydrogenase)IBA 04/2016 - 09/2003
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2012 - 05/2002
4	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 09/2016 - 12/2011
4	Cytotoxins (Cytolysins)IBA 04/2016 - 10/2003
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 05/2002
3	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 08/2005
3	Cisplatin (Platino)FDA LinkGeneric 12/2019 - 02/2004
3	AQ4NIBA 04/2016 - 12/2009
3	Complementary DNA (cDNA)IBA 04/2016 - 10/2003
3	rucaparibIBA 01/2015 - 10/2009
3	Hypoxia-Inducible Factor 1IBA 08/2014 - 04/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2012 - 05/2002
3	Transcription Factors (Transcription Factor)IBA 12/2011 - 02/2002
3	ProdrugsIBA 08/2005 - 10/2003
2	HydrogelsIBA 01/2023 - 10/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 12/2011
2	Gemcitabine FDA Link 07/2021 - 08/2014
2	LipidsIBA 10/2020 - 05/2018
2	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2020 - 01/2018
2	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2019 - 05/2018
2	Protein Isoforms (Isoforms)IBA 01/2019 - 06/2012
2	Palmitic Acid (Hexadecanoic Acid)IBA 01/2019 - 10/2015
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019 - 02/2002
2	Peptides (Polypeptides)IBA 03/2017 - 03/2010
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2017 - 10/2013
2	DNA (Deoxyribonucleic Acid)IBA 09/2016 - 01/2004
2	RacivirIBA 09/2016 - 12/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 12/2011
2	malic acid (malate)IBA 10/2015 - 10/2013
2	Pyruvic Acid (Pyruvate)IBA 10/2015 - 10/2013
2	Ketoglutaric Acids (Ketoglutaric Acid)IBA 10/2015 - 10/2013
2	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2013 - 12/2011
2	AntibodiesIBA 03/2013 - 01/2004
2	Adenosine Triphosphate (ATP)IBA 05/2011 - 02/2002
2	Mitogen-Activated Protein KinasesIBA 01/2011 - 11/2009
2	1- (4- dimethylaminomethylphenyl)- 8,9- dihydro- 7H- 2,7,9a- benzo(cd)azulen- 6- oneIBA 10/2009 - 01/2004
2	Irinotecan (Camptosar)FDA LinkGeneric 04/2007 - 01/2004
2	pimonidazoleIBA 06/2005 - 01/2004
2	Tirapazamine (SR 4233)IBA 06/2005 - 02/2004
2	ElementsIBA 04/2004 - 02/2004
2	Messenger RNA (mRNA)IBA 04/2004 - 05/2002
2	NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA 01/2004 - 09/2003
2	NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)IBA 01/2004 - 09/2003
2	quinone (benzoquinone)IBA 10/2003 - 01/2002
2	Glucose (Dextrose)FDA LinkGeneric 02/2002 - 01/2002
1	AlginatesIBA 01/2023
1	Adenosine Diphosphate (ADP)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Alanine (L-Alanine)FDA Link 01/2022
1	Vitamin K 3 (Menadione)FDA Link 07/2021
1	Radiation-Sensitizing AgentsIBA 07/2021
1	lissamine rhodamine B (sulforhodamine B)IBA 07/2021
1	Sirtuin 1IBA 01/2021
1	Proto-Oncogene Proteins c-mdm2IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2019
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	AcidsIBA 01/2019
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2019
1	14-fluoro-6-thiaheptadecanoic acidIBA 01/2019
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2019
1	Ethanolamine (Colamine)IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2018

Therapy/Procedure

24	Radiotherapy 01/2024 - 01/2004
21	Therapeutics 04/2022 - 01/2004
8	Drug Therapy (Chemotherapy) 04/2022 - 01/2002
2	Chemoradiotherapy 01/2019 - 12/2009
1	Combined Modality Therapy 01/2020
1	Immunotherapy 01/2019